| Literature DB >> 27536225 |
Natasha M Drissi1, Attila Szakács2, Suzanne T Witt3, Anna Wretman4, Martin Ulander5, Henriettae Ståhlbrandt6, Niklas Darin2, Tove Hallböök2, Anne-Marie Landtblom7, Maria Engström1.
Abstract
Narcolepsy is a chronic sleep disorder caused by a loss of hypocretin-1 producing neurons in the hypothalamus. Previous neuroimaging studies have investigated brain function in narcolepsy during rest using positron emission tomography (PET) and single photon emission computed tomography (SPECT). In addition to hypothalamic and thalamic dysfunction they showed aberrant prefrontal perfusion and glucose metabolism in narcolepsy. Given these findings in brain structure and metabolism in narcolepsy, we anticipated that changes in functional magnetic resonance imaging (fMRI) resting state network (RSN) dynamics might also be apparent in patients with narcolepsy. The objective of this study was to investigate and describe brain microstate activity in adolescents with narcolepsy and correlate these to RSNs using simultaneous fMRI and electroencephalography (EEG). Sixteen adolescents (ages 13-20) with a confirmed diagnosis of narcolepsy were recruited and compared to age-matched healthy controls. Simultaneous EEG and fMRI data were collected during 10 min of wakeful rest. EEG data were analyzed for microstates, which are discrete epochs of stable global brain states obtained from topographical EEG analysis. Functional MRI data were analyzed for RSNs. Data showed that narcolepsy patients were less likely than controls to spend time in a microstate which we found to be related to the default mode network and may suggest a disruption of this network that is disease specific. We concluded that adolescents with narcolepsy have altered resting state brain dynamics.Entities:
Keywords: default mode network; electroencephalography (EEG); functional magnetic resonance imaging (fMRI); microstates; narcolepsy; orexin; resting state networks; sleep
Year: 2016 PMID: 27536225 PMCID: PMC4971065 DOI: 10.3389/fnhum.2016.00369
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Adolescents with narcolepsy, demographics, clinical and laboratory characteristics.
| Patient | Gender | Age at scan (y) | Age at onset (y) | Narcolepsy duration (y) | BMI | Co-morbidity | Pandemrix vaccine | HLA DQB1*0602 | CSF-Hcrt (pg/ml) | MSLT | Narcolepsy subtype | Medications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 16.5 | 11 | 5 | 20.2 | 0 | No | Positive | 81 | Positive | 1 | Methylphenidate, Fluoxetine |
| 3 | M | 14.1 | 10 | 4 | 24.2 | Depression | Yes | Positive | <10 | Positive | 1 | Methylphenidate |
| 5 | F | 16.7 | 13 | 3 | 25.4 | 0c | Yes | Positive | <10 | Positive | 1 | Methylphenidate, Modafinil, Fluoxetine |
| 6 | F | 18.3 | 15 | 3 | 22.3 | Depression | Yes | Positive | 79 | Positive | 1 | None |
| 8 | M | 19 | 15 | 4 | 27.7 | Depression | Yes | Unknown | <10 | Positive | 1 | Methylphenidate |
| 9 | M | 18.4 | 15 | 3 | 23.9 | Depression | Yes | Positive | 49 | Positive | 1 | Methylphenidate |
| 10 | F | 19.5 | 15 | 4 | 24.4 | Depression | Yes | Unknown | Unknown | Positive | 1 | Methylphenidate, Sertraline |
| 11 | F | 18.3 | 15 | 3 | 22.5 | 0 | Yes | Positive | 18 | Positive | 1 | None |
| 12 | F | 20.2 | 16 | 4 | 25.2 | 0 | Yes | Positive | <10 | Positive | 1 | Notknown |
| 13 | M | 12.2 | 8 | 5 | Unknown | 0 | Yes | Positive | <10 | Unknown | 1 | Notknown |
| 15 | M | 15.3 | 13 | 2 | 27.4 | Depression | Yes | Positive | 58 | Positive | 1 | Methylphenidate, Fluoxetine |
| 16 | F | 17.9 | 14 | 3 | 41.4 | 0 | Yes | Positive | Unknown | Positive | 2 | Modafinil |
| 18 | F | 14.3 | 11 | 3 | 16.2 | 0 | Yes | Positive | Unknown | Positive | 1 | Modafinil, Fluoxetine |
| 19 | F | 14.3 | 10 | 4 | 20.9 | 0a | Yes | Positive | 10 | Positive | 1 | Methylphenidate |
| 20 | F | 17.3 | 13 | 5 | 38.4 | ADHDb | Yes | Positive | Unknown | Positive | 1 | Methylphenidate, Fluoxetine |
| 21 | F | 16.2 | 12 | 4 | 23.7 | 0a | Yes | Positive | <10 | Positive | 1 | Methylphenidate, Fluoxetine, Zolpidem |
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; CSF-Hcrt, Cerebrospinal Fluid Hypocretine; BMI; Body Mass Index; F, female; M, male. .
Patient data on day of examination.
| Patient | ESS score (0–24) | Cataplexy score (0–28) | Sleep efficacy (%) |
|---|---|---|---|
| 1 | 11 | 8 | 83 |
| 3 | 14 | 4 | 37 |
| 5 | 14 | 11 | 61 |
| 6 | 20 | 16 | 69 |
| 8 | 16 | 18 | 64 |
| 9 | 16 | 12 | 74 |
| 10 | 19 | 22 | 79 |
| 11 | 11 | 16 | 67 |
| 12 | 15 | 20 | 50 |
| 13 | 19 | 12 | 65 |
| 15 | 18 | 15 | 54 |
| 16 | 17 | 1 | 80 |
| 18 | 18 | 11 | 42 |
| 19 | 10 | 5 | 82 |
| 20 | 15 | 23 | 61 |
| 21 | 21 | 0 | 39 |
Table shows patient data on the day of the examination. ESS, Epworth Sleepiness Scale; Sleep efficacy is the proportion of sleep in the episode potentially filled by sleep.
Figure 1Topographical microstate maps. The figure shows the resulting four microstates, which are labeled (A–D) according to previous literature. The different colors signify the different polarities. The maps are represented as seen from above (A: Anterior, P: Posterior, L: Left, R: Right).
Figure 2Results from the electroencephalography (EEG) microstates analysis. The figure shows (A) mean duration of each microstate (in ms), (B) mean global explained variance (GEV), and (C) ratio of total time covered for each microstate. The error bars represent standard error. Descriptive data can be found in Table 3. “**” Indicates a significant post hoc difference. “°°” Indicates a trend-level post hoc difference.
Figure 3Microstate transition probability. The figure shows the probability of transition from one microstate to another with the results of the patients subtracted from the healthy controls. The vertical axis represents states at time point −1 and the horizontal axis shows states at time 1. The microstates are indicated A–D. No significant between-group differences were noted.
Figure 4Resting state networks (RSNs). This figure shows representative slices for each of the 15 RSNs. The functional connectivity maps are rendered as 1-sample t-tests (p < 0.05, family wise error (FWE) corrected for comparing across the whole brain) across the entire study sample of narcolepsy patients and healthy controls.
Descriptive data of the EEG microstates analysis.
| Map/Parameter | Patients | Controls | ||
|---|---|---|---|---|
| A | 87.58 | 101.44 | 6.11 | 1.03E-06 |
| B | 90.47 | 80.02 | 6.91 | 1.13E-07 |
| C | 75.92 | 72.92 | 8.81 | 7.96E-10 |
| D | 61.14 | 61.54 | n.s. | |
| A | 0.16 | 0.22 | 9.13 | 3.68E-10 |
| B | 0.19 | 0.14 | 5.09 | 1.81E-05 |
| C | 0.03 | 0.03 | 37.21 | 1.15E-26 |
| D | 0.11 | 0.12 | n.s. | |
| A | 0.33 | 0.41 | 7.70 | 1.36E-08 |
| B | 0.34 | 0.28 | 4.39 | 1.31E-04 |
| C | 0.22 | 0.21 | 17.12 | 4.94E-17 |
| D | 0.11 | 0.11 | n.s. |
The table shows the mean duration in milliseconds (ms), mean global explained variance, and ratio of total time for each microstate (A–D). *Indicates a significant multivariate effect (p < 0.05, corrected for comparing across one parameter). .
Description of resting state networks (RSNs).
| Left Pre-/Postcentral gyrus | 6 | −54 | −10 | 30 | 25.89 |
| Right Pre-/Postcentral gyrus | 6 | 66 | −2 | 24 | 20.79 |
| R Posterior cingulate | 29 | 8 | −48 | 14 | 35.52 |
| R Cingulate gyrus/Precuneus | 31 | 4 | −60 | 28 | 28.28 |
| L Cingulate gyrus/Precuneus | 31 | −2 | −54 | 30 | 33.36 |
| R Cingulate gyrus | 23 | 4 | −22 | 28 | 28.77 |
| R Calcarine | 18 | 18 | −104 | 0 | 31.73 |
| L Calcarine | 18 | −18 | −104 | −4 | 30.72 |
| R Hippocampus/Parahippocampus | 14 | −30 | −4 | 6.73 | |
| L Posterior cingulate | −12 | −56 | 14 | 7.24 | |
| L Cerebellum | −12 | −72 | −12 | 18.8 | |
| L Lingual gyrus | 18 | −14 | −80 | −14 | 19.76 |
| R Lingual gyrus | 18 | 18 | −80 | −10 | 18.48 |
| R Cerebellum | 26 | −86 | −20 | 17.62 | |
| Anterior cingulate/Superior frontal gyrus | 32, 10 | −4 | 44 | 4 | 29.26 |
| Precuneus | 31 | −2 | −58 | 28 | 28.51 |
| L Middle temporal/ Angular gyrus | 39 | −52 | −66 | 28 | 12.78 |
| R Middle temporal/ Angular gyrus | 39 | 56 | −60 | 28 | 10.78 |
| L Orbital frontal gyrus | 47 | −42 | 20 | −18 | 12.66 |
| R Orbital frontal gyrus | 47 | 40 | 12 | −12 | 7.35 |
| R Middle temporal gyrus | 58 | −62 | 0 | 27.44 | |
| L Middle occipital/Temporal gyrus | −46 | −78 | 2 | 19.58 | |
| Cingulate gyrus | 24, 32 | 2 | 2 | 44 | 13.00 |
| Left superior temporal lobe | 22 | −46 | 2 | −4 | 25.91 |
| Right superior temporal lobe | 22 | 56 | −4 | −2 | 22.36 |
| R Parahippocampus/Hippocampus/ Amygdala | 20 | 2 | −22 | 35.49 | |
| L Parahippocampus/Hippocampus/ Amygdala | −20 | 4 | −16 | 20.08 | |
| R Postcentral gyrus/ Supramarginal gyrus | 56 | −26 | 40 | 39.13 | |
| L Postcentral gyrus | −50 | −30 | 44 | 22.42 | |
| R Inf frontal gyrus | 44 | 54 | 8 | 16 | 10.80 |
| L Inf frontal | −50 | 6 | 14 | 9.16 | |
| L Middle frontal | −38 | 42 | 18 | 11.22 | |
| R Middle frontal | 36 | 40 | 16 | 7.65 | |
| R Inf temporal | 52 | −66 | −6 | 9.02 | |
| L Inf temporal | 37 | −48 | −66 | −2 | 9.37 |
| R Culmen | 24 | −54 | −26 | 8.01 | |
| L Culmen | −26 | −54 | −28 | 11.12 | |
| L Putamen | −16 | 16 | −4 | 38.64 | |
| R Caudate | 12 | 20 | −6 | 34.16 | |
| ACC | 32 | −4 | 36 | −6 | 28.66 |
| Supplementary motor area/ Middle cingulate gyrus | 6, 24 | 0 | −6 | 50 | 35.33 |
| Left precentral gyrus | 4, 6 | −36 | −16 | 46 | 19.97 |
| Right precentral gyrus | 6, 4 | 30 | −16 | 48 | 21.28 |
| ACC | 24, 32 | −4 | 24 | 28 | 26.92 |
| L Middle frontal gyrus | 9, 1 | −30 | 33 | 30 | 20.07 |
| R Middle/Superior frontal gyrus | 32 | 44 | 28 | 14.90 | |
| L Insula | −40 | 12 | −4 | 13.07 | |
| R Insula | 56 | 12 | −4 | 15.79 | |
| L Inferior frontal gyrus | −52 | 4 | 20 | 10.23 | |
| Medial occipital lobe/Lingual gyrus | 18 | −2 | −94 | −6 | 40.91 |
| R Caudate/Putamen | 16 | 6 | 8 | 23.38 | |
| L Caudate/Putamen | −10 | 4 | 4 | 27.12 | |
| L Putamen | −28 | −18 | 0 | 19.25 | |
| R Putamen | 28 | −16 | −2 | 20.16 | |
| ACC | −4 | 32 | 8 | 9.05 | |
| L Inf frontal | −48 | 26 | 6 | 7.23 | |
| L Thalamus | −8 | −26 | −6 | 15.91 | |
| R Thalamus | 10 | −14 | −2 | 16.64 | |
| R Caudate | 16 | 16 | 2 | 28.35 | |
| L Caudate | −10 | 8 | 4 | 25.99 | |
| L Middle/Superior temporal gyrus | 39 | −48 | −60 | 16 | 19.32 |
| L Precuneus | −22 | −62 | 16 | 19.13 | |
| R Precuneus | 16 | −56 | 14 | 17.24 | |
| R Middle/Superior temporal | 22 | 50 | −62 | 14 | 17.49 |
| Precuneus | 7 | −4 | −54 | 46 | 16.06 |
The table shows the peak Montreal Neurological Institute (MNI) stereotactic co-ordinates (x, y, z) for the 15 resting state network components submitted to temporal sorting based on the four microstate time courses. BA, Brodmann area. T, statistic value of the independent component resting state analysis.
Figure 5Temporal correlation of EEG microstates and functional magnetic resonance imaging (fMRI) RSNs. This figure shows the results of the temporal sorting of the RSNs using the time courses of the four EEG microstates. Results are stratified in terms of microstate and study group, with results for the narcolepsy patients and controls displayed separately. The temporal sorting regression coefficients are displayed in terms of Z-scores. *Indicates a temporal correlation with a Z-score >1.
Summary of the temporal correlation analyses between the EEG microstates and the fMRI RSNs.
| Microstate A | Microstate B | Microstate C | Microstate D | |||||
|---|---|---|---|---|---|---|---|---|
| Component # | Narcolepsy | Healthy | Narcolepsy | Healthy | Narcolepsy | Healthy | Narcolepsy | Healthy |
| 1 | −0.47 | 0.35 | 0.62 | 0.41 | 0.76 | −0.16 | 0.18 | −0.46 |
| 2 | 1.41 | 1.04 | −0.32 | 0.86 | −0.95 | 0.97 | −0.49 | 0.70 |
| 3 | −0.81 | 0.54 | 0.64 | 0.82 | 0.81 | 0.76 | 1.09 | 0.81 |
| 4 | 1.04 | 0.14 | 0.67 | 0.61 | 2.25 | 0.58 | 2.37 | 0.97 |
| 5 | −1.60 | −2.51 | 0.80 | −0.95 | −1.35 | −1.70 | 0.26 | 0.56 |
| 6 | −0.09 | 0.11 | 0.52 | 0.55 | 0.21 | 0.61 | 0.47 | 1.04 |
| 7 | 0.00 | 0.16 | 0.16 | 1.11 | 0.19 | 1.13 | −0.18 | 0.84 |
| 8 | −0.14 | −0.38 | 0.21 | 0.34 | −1.39 | 0.04 | −0.63 | 0.13 |
| 9 | −0.15 | −0.32 | 0.37 | −0.31 | 1.16 | −0.66 | −0.47 | −0.50 |
| 10 | 1.33 | 2.15 | −1.72 | −2.39 | −1.01 | 0.76 | −1.51 | −1.86 |
| 11 | 0.14 | −1.64E-04 | −1.35 | −0.40 | −0.05 | −0.95 | −0.19 | −0.40 |
| 12 | −1.67 | −0.95 | −2.14 | −1.66 | −0.65 | −2.27 | −0.94 | −2.36 |
| 13 | 1.59 | −0.06 | 0.92 | 0.50 | 0.24 | 0.44 | 0.74 | 0.04 |
| 14 | −3.44E-03 | −0.53 | −0.45 | 0.70 | −0.33 | −0.08 | −1.35 | 0.07 |
| 15 | −0.59 | 0.28 | 1.06 | −0.20 | 0.13 | 0.54 | 0.65 | 0.41 |
The table shows the z-score value of the temporal correlation between the time courses of each EEG microstate and the time courses of each of the 15 RSNs.
Figure 6Sleep stages during the fMRI-EEG examination. The figure shows percent time spent in wake (W), sleep stage 1 (N1), sleep stage 2 (N2), sleep stage 3 (N3), and rapid eye movement (REM) sleep for narcolepsy patients and controls, respectively. The error bars represent the standard deviation.